Medicare Enrolled
Dr. Purvi Saraiya, MD
Neurology · Toledo, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Saraiya from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saraiya?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Saraiya
Dr. Purvi Saraiya is a neurology specialist in Toledo, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Saraiya performed 947 Medicare services across 772 unique beneficiaries.
Between the years covered by Open Payments, Dr. Saraiya received a total of $27,511 from 87 pharmaceutical and/or device companies across 1550 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Saraiya is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in OH
$27,511 industry payments
Medicare Practice Summary
Medicare Utilization ↗947
Medicare services
Top 16% in OH for neurology
772
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~47 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
304 | $87 | $202 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
240 | $58 | $139 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
152 | $72 | $161 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
81 | $105 | $299 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
32 | $123 | $340 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $123 | $278 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
20 | $157 | $399 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
19 | $96 | $245 |
| Nerve conduction study, 3-4 tests A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function. |
16 | $78 | $216 |
| New patient office visit, complex (60-74 min) | 12 | $167 | $397 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $25 | $83 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
12 | $38 | $58 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
11 | $43 | $87 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $62 | $197 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$27,511
Total received (2018-2024)
Avg $3,930/year across 7 years
Top 17% in OH for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
87
Companies
1,550
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,063 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$448 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,112
2023
$5,594
2022
$4,553
2021
$4,130
2020
$2,716
2019
$3,439
2018
$2,968
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$499
Novartis Pharmaceuticals Corporation
$380
ABBVIE INC.
$337
PFIZER INC.
$274
Teva Pharmaceuticals USA, Inc.
$215
UCB, Inc.
$211
Kyowa Kirin, Inc.
$207
SK Life Science, Inc.
$204
Biogen, Inc.
$203
Alexion Pharmaceuticals, Inc.
$196
CATALYST PHARMACEUTICALS, INC.
$177
Genentech USA, Inc.
$163
ACADIA Pharmaceuticals Inc
$161
TG Therapeutics, Inc.
$133
Lilly USA, LLC
$96
E.R. Squibb & Sons, L.L.C.
$94
Celgene Corporation
$78
ARGENX US, INC.
$78
Lundbeck LLC
$72
Neurocrine Biosciences, Inc.
$59
Neurelis, Inc.
$34
LivaNova USA, Inc.
$27
Otsuka America Pharmaceutical, Inc.
$26
Sumitomo Pharma America, Inc.
$22
Amgen Inc.
$22
Vanda Pharmaceuticals Inc.
$19
Amneal Pharmaceuticals LLC
$19
Merz Pharmaceuticals, LLC
$18
JAZZ PHARMACEUTICALS INC.
$17
Boston Scientific Corporation
$17
Mylan Specialty L.P.
$16
Eisai Inc.
$15
AstraZeneca Pharmaceuticals LP
$13
Aucta Pharmaceuticals, Inc.
$10
Top 3 companies account for 29.6% of 2024 payments
All-time payments by company (2018-2024) ›
EMD Serono, Inc.
$2,943
Novartis Pharmaceuticals Corporation
$2,386
Biogen, Inc.
$2,159
Teva Pharmaceuticals USA, Inc.
$1,632
LivaNova USA, Inc.
$1,455
SK Life Science, Inc.
$1,095
UCB, Inc.
$1,091
ACADIA Pharmaceuticals Inc
$944
Genentech USA, Inc.
$909
Alexion Pharmaceuticals, Inc.
$742
ABBVIE INC.
$693
Supernus Pharmaceuticals, Inc.
$691
GENZYME CORPORATION
$666
Lilly USA, LLC
$661
Lundbeck LLC
$646
AbbVie Inc.
$627
Amgen Inc.
$583
PFIZER INC.
$448
Janssen Pharmaceuticals, Inc
$442
Amneal Pharmaceuticals LLC
$415
Acorda Therapeutics, Inc
$396
Celgene Corporation
$370
Eisai Inc.
$328
Kyowa Kirin, Inc.
$325
CSL Behring
$315
Neurelis, Inc.
$277
Biohaven Pharmaceutical Holding Company Ltd.
$213
Adamas Pharmaceuticals, Inc.
$203
CATALYST PHARMACEUTICALS, INC.
$201
Horizon Therapeutics plc
$193
Avanir Pharmaceuticals, Inc.
$192
ARGENX US, INC.
$180
E.R. Squibb & Sons, L.L.C.
$169
Biohaven Pharmaceuticals, Inc.
$169
Allergan, Inc.
$154
Alnylam Pharmaceuticals Inc.
$151
Sunovion Pharmaceuticals Inc.
$146
EISAI INC.
$143
TG Therapeutics, Inc.
$133
JAZZ PHARMACEUTICALS INC.
$124
Allergan Inc.
$124
US WorldMeds, LLC
$110
Mitsubishi Tanabe Pharma America, Inc.
$108
Neurocrine Biosciences, Inc.
$100
IMPEL PHARMACEUTICALS INC.
$82
UPSHER-SMITH LABORATORIES LLC
$80
Impax Laboratories, Inc.
$78
Grifols USA, LLC
$68
TG THERAPEUTICS, INC.
$65
Mallinckrodt LLC
$62
Bausch Health US, LLC
$60
Assertio Therapeutics, Inc.
$60
Otsuka America Pharmaceutical, Inc.
$60
Bayer HealthCare Pharmaceuticals Inc.
$59
Genentech, Inc.
$48
Takeda Pharmaceuticals U.S.A., Inc.
$47
Greenwich Biosciences, Inc.
$46
Mallinckrodt Hospital Products Inc.
$45
AstraZeneca Pharmaceuticals LP
$44
Amylyx Pharmaceuticals, Inc.
$44
Cala Health, Inc.
$43
Catalyst Pharmaceuticals, Inc.
$38
ASSERTIO THERAPEUTICS, Inc.
$28
Mallinckrodt Enterprises LLC
$26
Upsher-Smith Laboratories LLC
$24
Sumitomo Pharma America, Inc.
$22
Nevro Corp.
$21
Vanda Pharmaceuticals Inc.
$19
Avion Pharmaceuticals
$19
BANNER LIFE SCIENCES, LLC
$19
Merz Pharmaceuticals, LLC
$18
Mylan Pharmaceuticals Inc.
$18
Medtronic, Inc.
$18
MDD US Operations, LLC
$18
BOSTON SCIENTIFIC CORPORATION
$17
Boston Scientific Corporation
$17
Aprecia Pharmaceuticals, LLC
$17
Mylan Specialty L.P.
$16
Egalet US Inc
$14
ADVANCED RESPIRATORY, INC
$14
Corium, LLC
$13
Zogenix Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$12
Almatica Pharma LLC
$12
Vertical Pharmaceuticals, LLC
$11
Ceribell, Inc.
$11
Aucta Pharmaceuticals, Inc.
$10
Top 3 companies account for 27.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX COSMETIC · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · CALA KIQ · CALA TRIO · CAMBIA · COPAXONE · Cambia · DUOPA · Dhivy · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GENERAL PAIN MANAGEMENT · GILENYA · GLATIRAMER ACETATE · GOCOVRI · GRALISE · Gamunex-C · Glatiramer Acetate · Gralise · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MS DISEASE STATE · Mavenclad · Motpoly XR · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Omnia · PERCEPT PC BRAINSENSE · PLEGRIDY · PONVORY · Ponvory · QULIPTA · RELEXXII · RELYVRIO · REXULTI · REYVOW · RYTARY · Radicava · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · SPRIX · SUNOSI · Soliris · Spritam · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · The Vest System Model 105 Home Care · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XCOPRI · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
48
Per 100K population
11.2
County median income
$60,095
Nearest hospital
PROMEDICA TOLEDO HOSPITAL
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Saraiya is a clinical cardiology specialist, with above-average Medicare volume (top 16% in OH), with low-engagement industry engagement in the top 17% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Saraiya experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Saraiya performed 304 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Saraiya receive payments from pharmaceutical companies?
Yes. Dr. Saraiya received a total of $27,511 from 87 companies across 1,550 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saraiya's costs compare to other neurologists in Toledo?
Dr. Saraiya's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saraiya) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Toledo
Browse neurologists in Toledo ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in OH
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in OH
Which OH neurologists receive the most from drug and device companies.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology